Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cannabis sativa is a plant that contains over 500 different components, including cannabinoids like delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). These compounds interact with the endocannabinoid system (ECS) in the human body, which regulates many physiological processes including immune response, cardiovascular activity, memory, and pain sensation. The plant produces a unique class of terpenophenolic compounds called cannabinoids, as well as non-cannabinoid compounds that contribute to its medicinal effects. Cannabis sativa has been used historically for the treatment of various conditions including rheumatism, epilepsy, asthma, skin burns, pain, sexually transmitted diseases, and gastrointestinal issues.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cannabis sativa.